Effect of benzodiazepines on community-acquired pneumonia
| Benzodiazepins use | Controls (n=1326) | Cases (n=1336) | p | OR (CI 95%) |
|---|---|---|---|---|
| Overall sample | 121 (9.2%) | 111 (8.3%) | 0.455 | 0.90 (0.69 to 1.18) |
| ≤60 years old | 46 (7.0%) | 26 (3.9%) | 0.012 | 0.54 (0.33 to 0.88) |
| >60 years old | 75 (11.5%) | 85 (12.9%) | 0.428 | 1.14 (0.82 to 1.59) |
| Only ≤60-year-old subjects | ||||
| Half-life | ||||
| No use of BZ | 614 (93.0%) | 648 (96.3%) | 1 | |
| Low | 4 (0.6%) | 1 (0.1%) | 0.024 | 0.24 (0.03 to 2.13) |
| Medium-high | 42 (6.4%) | 24 (3.6%) | 0.54 (0.32 to 0.91) | |
| Hypnotic power | ||||
| No use of BZ | 614 (93.0%) | 648 (96.3%) | 1 | |
| Low | 10 (1.5%) | 11 (1.6%) | 0.007 | 1.04 (0.44 to 2.47) |
| Medium-high | 35 (5.3%) | 14 (2.1%) | 0.38 (0.20 to 0.71) | |
| Miorelaxant power | ||||
| No use of BZ | 614 (93.0%) | 648 (96.3%) | 1 | |
| Low | 23 (3.5%) | 14 (2.1%) | 0.036 | 0.58 (0.29 to 1.13) |
| Medium-high | 22 (3.3%) | 11 (1.6%) | 0.47 (0.23 to 0.99) | |
| Anxyolitic power | ||||
| No use of BZ | 614 (93.0%) | 648 (96.3%) | 1 | |
| Low | 2 (0.3%) | 1 (0.1%) | 0.039 | 0.47 (0.04 to 5.24) |
| Medium-high | 43 (6.5%) | 24 (3.6%) | 0.53 (0.32 to 0.88) | |
BZ, Benzodiazepines.